ADRENERGIC MODULATION OF EXTRARENAL POTASSIUM DISPOSAL IN MEN WITH END-STAGE RENAL-DISEASE

被引:27
作者
ALLON, M [1 ]
SHANKLIN, N [1 ]
机构
[1] VET ADM MED CTR,BIRMINGHAM,AL 35233
关键词
D O I
10.1038/ki.1991.321
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In normal subjects, beta-adrenergic stimulation lowers the serum potassium, whereas alpha-stimulation raises it. Epinephrine, a mixed alpha and beta agonist, acutely lowers the blood potassium in normal subjects, but not in patients with end-stage renal disease. This study was designed to determine whether the resistance to the hypokalemic effect of epinephrine in dialysis patients is due to a blunted beta-adrenergic response, or to an augmented alpha-adrenergic response. The infusion of epinephrine at low doses (0.01-mu-g/kg/min) produced a significant increase in serum potassium in hemodialysis patients (+0.21 +/- 0.07 mmol/liter, P < 0.05), as compared to a nonsignificant decrease (-0.06 +/- 0.04 mmol/liter) in normal subjects. Epinephrine at high physiologic doses (0.04-mu-g/kg/min) failed to significantly change the serum potassium in the dialysis patients (-0.10 +/- 0.14 mmol/liter), but substantially lowered serum potassium in the controls (-0.64 +/- 0.10 mmol/liter, P < 0.001). There was no significant correlation (r = 0.03) between the baseline serum potassium concentration and the magnitude of change during epinephrine infusion. Epinephrine infusion (0.04-mu-g/kg/min) during beta-blockade with propranolol produced a greater rise in serum potassium in the dialysis patients as compared to the controls (+0.69 +/- 0.11 vs. +0.32 +/- 0.11 mmol/liter, P < 0.05). Epinephrine infusion (0.01-mu-g/kg/min) during alpha-blockade with phentolamine resulted in similar changes in serum potassium in dialysis patients and in normal control (-0.10 +/- 0. 12 vs. -0.10 +/- 0.06 mmol/liter). Moreover, phentolamine reversed the increase in serum potassium observed in dialysis patients during the infusion of epinephrine following beta-blockade. These results suggest that hemodialysis patients have an impaired extrarenal clearance of potassium in response to epinephrine, that is attributable to an enhanced hyperkalemic response to alpha-adrenergic stimulation.
引用
收藏
页码:1103 / 1109
页数:7
相关论文
共 29 条
[1]   NEBULIZED ALBUTEROL FOR ACUTE HYPERKALEMIA IN PATIENTS ON HEMODIALYSIS [J].
ALLON, M ;
DUNLAY, R ;
COPKNEY, C .
ANNALS OF INTERNAL MEDICINE, 1989, 110 (06) :426-429
[2]   ALBUTEROL AND INSULIN FOR TREATMENT OF HYPERKALEMIA IN HEMODIALYSIS-PATIENTS [J].
ALLON, M ;
COPKNEY, C .
KIDNEY INTERNATIONAL, 1990, 38 (05) :869-872
[3]  
BLUMBERG A, 1988, AM J MED, V85, P507
[4]   EPINEPHRINE IS A HYPOPHOSPHATEMIC HORMONE IN MAN - PHYSIOLOGICAL-EFFECTS OF CIRCULATING EPINEPHRINE ON PLASMA CALCIUM, MAGNESIUM, PHOSPHORUS, PARATHYROID-HORMONE, AND CALCITONIN [J].
BODY, JJ ;
CRYER, PE ;
OFFORD, KP ;
HEATH, H .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (03) :572-578
[5]   HYPOKALEMIA FROM BETA-2-RECEPTOR STIMULATION BY CIRCULATING EPINEPHRINE [J].
BROWN, MJ ;
BROWN, DC ;
MURPHY, MB .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (23) :1414-1419
[6]   EXTRARENAL POTASSIUM HOMEOSTASIS [J].
BROWN, RS ;
CANZANELLO, VJ ;
PERRONE, R ;
LEVEY, AS ;
KASSIRER, JP ;
MADIAS, NE .
KIDNEY INTERNATIONAL, 1986, 30 (01) :116-127
[7]   MECHANISMS OF AUTONOMIC NERVOUS-SYSTEM DYSFUNCTION IN UREMIA [J].
CAMPESE, VM ;
ROMOFF, MS ;
LEVITAN, D ;
LANE, K ;
MASSRY, SG .
KIDNEY INTERNATIONAL, 1981, 20 (02) :246-253
[8]   PLASMA-FREE, SULFO-CONJUGATED AND GLUCURO-CONJUGATED CATECHOLAMINES IN UREMIC PATIENTS [J].
CUCHE, JL ;
PRINSEAU, J ;
SELZ, F ;
RUGET, G ;
BAGLIN, A .
KIDNEY INTERNATIONAL, 1986, 30 (04) :566-572
[9]   EPINEPHRINE AND POTASSIUM HOMEOSTASIS [J].
DEFRONZO, RA ;
BIA, M ;
BIRKHEAD, G .
KIDNEY INTERNATIONAL, 1981, 20 (01) :83-91
[10]  
FERNANDEZ J, 1986, MINER ELECTROL METAB, V12, P125